Applied Therapeutics Inc. (NASDAQ: APLT) Stock Information | RedChip

Applied Therapeutics Inc. (NASDAQ: APLT)


$0.9286
-0.0914 ( -2.25% ) 6.0M

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Market Data


Open


$0.9286

Previous close


$1.0200

Volume


6.0M

Market cap


$101.84M

Day range


$0.8420 - $1.0150

52 week range


$0.8420 - $10.6237

SEC Filings


Form Type Description Pages Date
10-k Annual reports 114 Mar 06, 2024
8-k 8K-related 19 Feb 29, 2024
8-k 8K-related 14 Feb 15, 2024
8-k 8K-related 12 Jan 04, 2024
8-k 8K-related 12 Jan 03, 2024
8-k 8K-related 13 Dec 29, 2023
4 Insider transactions 1 Dec 22, 2023
4 Insider transactions 1 Dec 22, 2023
4 Insider transactions 1 Dec 22, 2023
4 Insider transactions 1 Dec 05, 2023

Latest News